342 related articles for article (PubMed ID: 2864160)
1. Use of carbamazepine in psychiatric disorders.
Birkhimer LJ; Curtis JL; Jann MW
Clin Pharm; 1985; 4(4):425-34. PubMed ID: 2864160
[TBL] [Abstract][Full Text] [Related]
2. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic and prophylactic effects of carbamazepine in bipolar disorders.
Okuma T
Psychiatr Clin North Am; 1983 Mar; 6(1):157-74. PubMed ID: 6351033
[TBL] [Abstract][Full Text] [Related]
4. Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
Campbell M; Cueva JE
J Am Acad Child Adolesc Psychiatry; 1995 Oct; 34(10):1262-72. PubMed ID: 7592263
[TBL] [Abstract][Full Text] [Related]
5. Divalproex sodium in the treatment of refractory affective disorders.
Schaff MR; Fawcett J; Zajecka JM
J Clin Psychiatry; 1993 Oct; 54(10):380-4. PubMed ID: 8262880
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of carbamazepine compared with other agents: a clinical practice survey.
Denicoff KD; Meglathery SB; Post RM; Tandeciarz SI
J Clin Psychiatry; 1994 Feb; 55(2):70-6. PubMed ID: 8077157
[TBL] [Abstract][Full Text] [Related]
7. The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants.
Fawcett J; Kravitz HM
J Clin Psychiatry; 1985 Feb; 46(2):58-60. PubMed ID: 3968046
[TBL] [Abstract][Full Text] [Related]
8. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
Goodwin FK
J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
[TBL] [Abstract][Full Text] [Related]
9. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
10. Fundamentals of carbamazepine use in neuropsychiatry.
Neppe VM; Tucker GJ; Wilensky AJ
J Clin Psychiatry; 1988 Apr; 49 Suppl():4-6. PubMed ID: 3280561
[TBL] [Abstract][Full Text] [Related]
11. Profile of clinical efficacy and side effect of carbamazepine in psychiatric illness: relationship to blood and CSF levels of carbamazepine and its -10,11-epoxide metabolite.
Post RM; Uhde TW; Wolff EA
Acta Psychiatr Scand Suppl; 1984; 313():104-20. PubMed ID: 6367365
[No Abstract] [Full Text] [Related]
12. [Are mood stabilizers beneficial in the treatment of schizophrenia?].
Berle JØ; Spigset O
Tidsskr Nor Laegeforen; 2005 Jun; 125(13):1809-12. PubMed ID: 16012547
[TBL] [Abstract][Full Text] [Related]
13. A lithium and carbamazepine combination in the treatment of bipolar disorder--a preliminary report.
Inoue K; Arima S; Tanaka K; Fukui Y; Kato N
Folia Psychiatr Neurol Jpn; 1981; 35(4):465-75. PubMed ID: 6806160
[TBL] [Abstract][Full Text] [Related]
14. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients.
Placidi GF; Lenzi A; Lazzerini F; Cassano GB; Akiskal HS
J Clin Psychiatry; 1986 Oct; 47(10):490-4. PubMed ID: 3093468
[TBL] [Abstract][Full Text] [Related]
15. [Carbamazepine in the treatment of psychiatric diseases: effects and side effects].
Rittmannsberger H
Wien Med Wochenschr; 1990 Aug; 140(15):398-404. PubMed ID: 2244387
[TBL] [Abstract][Full Text] [Related]
16. Clozapine in severe mood disorders.
Zarate CA; Tohen M; Baldessarini RJ
J Clin Psychiatry; 1995 Sep; 56(9):411-7. PubMed ID: 7665540
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
[TBL] [Abstract][Full Text] [Related]
18. Treatment of aggression in patients with bipolar disorder.
Swann AC
J Clin Psychiatry; 1999; 60 Suppl 15():25-8. PubMed ID: 10418811
[TBL] [Abstract][Full Text] [Related]
19. Introduction: the use of mood stabilizers in the treatment of psychiatric disorders.
Bowden CL
J Clin Psychiatry; 1999; 60 Suppl 5():3-4. PubMed ID: 10192401
[No Abstract] [Full Text] [Related]
20. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
Ketter TA; Post RM; Parekh PI; Worthington K
J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
